mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-09 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-09 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-08 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-07 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-06 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |